Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7ZQP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,064
Award facts
- Contract value 100% obligated
- $24,064.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 27, 2025, for the supply of Beyfortus 50 mg/0.5 mL syringes with a ceiling value of $24,064.20. This is a firm fixed-price delivery order with an ultimate completion date of December 29, 2025, and was competitively awarded without set-aside designation. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply an extensive range of pharmaceuticals, vaccines, and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for medical procurement supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Beyfortus (nirsevimab) is a monoclonal antibody administered to infants to prevent respiratory syncytial virus (RSV) infection, reflecting the company's role in supplying specialized immunizations and preventive care products to military medical supply chains. This delivery order demonstrates the contractor's established capability to meet federal procurement requirements through open competition and supports the DLA's strategic medical supply operations.
Quick answers
Who was awarded contract SPE2DR26F7ZQP?
SPE2DR26F7ZQP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 27, 2025.
How much is contract SPE2DR26F7ZQP worth?
The government has obligated $24,064 on SPE2DR26F7ZQP.
Is contract SPE2DR26F7ZQP an order under another contract?
Yes. SPE2DR26F7ZQP is a delivery order under SPE2DR25D7066, an indefinite delivery contract.
Was contract SPE2DR26F7ZQP competed?
The extent of competition for SPE2DR26F7ZQP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award